1,144
Views
6
CrossRef citations to date
0
Altmetric
REVIEW

Novel Immunotherapies for Myasthenia Gravis

& ORCID Icon
Pages 25-45 | Received 08 Jan 2023, Accepted 03 Mar 2023, Published online: 04 Apr 2023

Figures & data

Table 1 Summary of the Newer Molecules for Myasthenia Gravis Therapy

Figure 1 Targets of novel therapeutic agents in myasthenia gravis.

Figure 1 Targets of novel therapeutic agents in myasthenia gravis.

Table 2 Summary of Systematic Reviews, Randomized Trials, and Prospective Studies of Rituximab in Myasthenia Gravis